Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model
AUTOR(ES)
Urt-Filho, Antônio, Oliveira, Rodrigo Juliano, Hermeto, Larissa Correa, Pesarini, João Renato, David, Natan de, Cantero, Wilson de Barros, Falcão, Gustavo, Marks, Guido, Antoniolli-Silva, Andréia Conceição Milan Brochado
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
03/06/2016
RESUMO
Abstract Acute renal failure (ARF) is an extremely important public health issue in need of novel therapies. The present study aimed to evaluate the capacity of mesenchymal stem cell (MSC) therapy to promote the improvement and recovery of renal function in a preclinical model. Wistar rats were used as the experimental model, and our results show that cisplatin (5mg/kg) can efficiently induce ARF, as measured by changes in biochemical (urea and creatinine) and histological parameters. MSC therapy performed 24h after the administration of chemotherapy resulted in normalized plasma urea and creatinine levels 30 and 45d after the onset of kidney disease. Furthermore, MSC therapy significantly reduced histological changes (intratubular cast formation in protein overload nephropathy and tubular hydropic degeneration) in this ARF model. Thus, considering that current therapies for ARF are merely palliative and that MSC therapy can promote the improvement and recovery of renal function in this model system, we suggest that innovative/alternative therapies involving MSCs should be considered for clinical studies in humans to treat ARF.
Documentos Relacionados
- Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives
- Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model
- Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure.
- bFGF promotes adipocyte differentiation in human mesenchymal stem cells derived from embryonic stem cells
- Adhesion to Vitronectin and Collagen I Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells